Technical Analysis for SNPHY - Santen Pharmaceutical Co

Grade Last Price % Change Price Change
grade A 17.37 0.14% 0.0250
SNPHY closed up 0.14 percent on Friday, August 23, 2019, on 61 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical SNPHY trend table...

Date Alert Name Type % Chg
Cup with Handle Other 0.00%
Overbought Stochastic Strength 0.00%
Cup with Handle Other 0.14%
Narrow Range Bar Range Contraction 0.14%
Overbought Stochastic Strength 0.14%
New 52 Week Closing High Bullish -0.17%
Pocket Pivot Bullish Swing Setup -0.17%
Narrow Range Bar Range Contraction -0.17%
Above Upper BB Strength -0.17%
Gapped Up Strength -0.17%

Older signals for SNPHY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Santen Pharmaceutical Co., Ltd. researches and develops, produces, and markets pharmaceuticals and medical devices in Japan and internationally. It offers prescription pharmaceutical products for glaucoma and ocular hypertension, dry eyes, allergic conjunctivitis, severe keratitis with dry eyes, vernal keratoconjunctivitis, uveitis, wet age-related macular degeneration, and myopia; and over-the-counter pharmaceutical products. The company was formerly known as Santendo Pharmaceutical Co., Ltd. and changed its name to Santen Pharmaceutical Co., Ltd. in 1958. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan.
Medicine Health RTT Medical Specialties Glaucoma Conjunctivitis Over The Counter Pharmaceutical Products Wet Age Related Macular Degeneration Allergic Conjunctivitis Prescription Pharmaceutical Products Markets Pharmaceuticals Myopia Ocular Hypertension Pharmaceuticals And Medical Devices Keratoconjunctivitis Santen Pharmaceutical Severe Keratitis Uveitis Vernal Keratoconjunctivitis
Is SNPHY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 17.5
52 Week Low 12.76
Average Volume 10,558
200-Day Moving Average 15.3733
50-Day Moving Average 16.5019
20-Day Moving Average 16.8253
10-Day Moving Average 17.0196
Average True Range 0.2786
ADX 16.31
+DI 35.7225
-DI 28.2395
Chandelier Exit (Long, 3 ATRs ) 16.5642
Chandelier Exit (Short, 3 ATRs ) 16.7758
Upper Bollinger Band 17.5244
Lower Bollinger Band 16.1262
Percent B (%b) 0.89
BandWidth 8.310104
MACD Line 0.2544
MACD Signal Line 0.2104
MACD Histogram 0.044
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.8200
Resistance 3 (R3) 17.7700 17.5700 17.7450
Resistance 2 (R2) 17.5700 17.4554 17.5950 17.7200
Resistance 1 (R1) 17.4700 17.3846 17.5200 17.5200 17.6950
Pivot Point 17.2700 17.2700 17.2950 17.2950 17.2700
Support 1 (S1) 17.1700 17.1554 17.2200 17.2200 17.0450
Support 2 (S2) 16.9700 17.0846 16.9950 17.0200
Support 3 (S3) 16.8700 16.9700 16.9950
Support 4 (S4) 16.9200